hft lawsuit in us against major us banks, page-39

I'd call the fDA news significant if not very significant! maybe it was priced in and that was the problem I don't know, it doesn't take away from the importance of getting such approval, what if they didn't? then you would have noticed just how important it was! in a more accommodative climate I still think it would have gone beyond the 20's which many including me would have sold into but it wasn't to be, no stress however the company now has every chance to prove itself whether it matters with lesser barriers than before, time to add a zero or two to the figures on the financial sheets - game time!